Sanofi shares fall as Elf cuts holding
This article was originally published in Clinica
Executive Summary
Elf Aquitaine is to sell E4.3 billion ($4.5 billion) of its holdings in Sanofi-Synthelabo. This leaves the oil multinational with a 19.5% interest in the French pharmaceuticals and medical devices group, which was formed in a merger earlier this year.